Stocks and Investing Stocks and Investing
Thu, May 10, 2012
Wed, May 9, 2012
[ Wed, May 09th 2012 ] - Market Wire
Annual General Meeting Results
Tue, May 8, 2012
Mon, May 7, 2012
Sun, May 6, 2012
Sat, May 5, 2012
Fri, May 4, 2012
[ Fri, May 04th 2012 ] - Market Wire
Dorato Provides Update
Thu, May 3, 2012

Matthew Harrison Upgraded (VRTX) to Hold and Increased Target to $51 on, May 8th, 2012


//stocks-investing.news-articles.net/content/201 .. -and-increased-target-to-51-on-may-8th-2012.html
Published in Stocks and Investing on Thursday, October 24th 2024 at 23:40 GMT by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Increased Target from $28 to $51 on, May 8th, 2012.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $49 on, Wednesday, March 14th, 2012

Publication Contributing Sources